NA-921 (Bionetide)

NA-921 · Biomed Industries, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NA-921 (Bionetide), covering 2025-02-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome [Phase 3]

See pricing